In this instalment of Robert MacNeill’s column, he explores the giddy realm of chromatographic bioanalysis and the less well-known phenomena that can affect band migration through a column.
At a time where the world is looking to repurposed drugs to give the quickest treatment option to the COVID-19 pandemic, we interview David Fajgenbaum (University of Pennsylvania (PA, USA) and bestselling author of ‘Chasing My Cure’) on what type of treatment he considers to hold the most promise.
Rawi Ramautar Biomedical Microscale Analytics Leiden Academic Centre for Drug Research Leiden University, The Netherlands…
In this editorial, the author discusses the progression of the metabolomics field, the growing number of databases that are appearing and new separation techniques such as ion mobility, which are adding a fourth dimension to identification capabilities.
In this Learn with Lin article, Zone Leader Lin Wang (Covance, NJ, USA) explores the different components of a LC–MS and explains how they work.
New study published in Current Research in Biotechnology reports the development of a model for computational prediction of glycosylation of recombinant proteins, which would be of a very high value in the development of future biopharmaceuticals.
High-resolution mass spectrometry has come a long way since its inception. As the field continues to evolve, take a look at the applications of HRMS. From exact mass to routine analyses, what’s next?
Almost nothing is known about the importance of protein PTMs in ALS disease progression. Ben Orsburn (Chief Scientist, Proteomic und Genomic Sciences, MD, USA) is inviting you to change that. In this editorial discover the #ALSMinePTMs community project.
Biomarkers are used to improve diagnosis and monitor a therapeutic response. During biomarker discovery ideal candidates are identified.
With coronavirus disease 2019 (COVID-19) shutting down countries and economies, the world is expectantly looking at scientists to come up with a solution.